You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-MCM7 antibody [47DC141] (ab2360)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-MCM7 antibody [47DC141]
See all MCM7 products (10) ...

Description

Mouse monoclonal [47DC141] to MCM7

Tested applications

IF, IHC-P, IP, WB, Flow Cyt, ICC/IFmore details

Cross reactivity

Reacts with

Mouse, Rat, Dog, Human, Xenopus laevis

Immunogen

Recombinant full length protein (Human).

Positive control

Breast carcinoma, MAD109 cell lysate, PC12 cell lysate.

Properties

Form

Liquid

Storage instructions

Store at +4°C. Do not freeze.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: 1% BSA

Concentration

Concentration information loading...

Purity

IgG fraction

Clonality

Monoclonal

Clone number

47DC141

Myeloma

unknown

Isotype

IgG1

Light chain type

unknown

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - MCM7 antibody [47DC141] (ab2360)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - MCM7 antibody [47DC141] (ab2360) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - MCM7 antibody [47DC141] (ab2360)Immunocytochemistry/ Immunofluorescence - MCM7 antibody [47DC141] (ab2360) image (enlarge)

  • Western blot - MCM7 antibody [47DC141] (ab2360)Western blot - MCM7 antibody [47DC141] (ab2360) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab2360 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide

    IF

     IF: Use at an assay depe...Read more →

    IF: Use at an assay dependent dilution.

  • IHC-P: 1/50 - 1/100.(This is when using an ABC method for 30 minutes at room temperature. Sections require high temperature antigen unmasking with 10 mM citrate buffer, pH 6.0 prior to immunostaining.)

  • ShowHide

    IP

     IP: Use at 2 µg/mg of ly...Read more →

    IP: Use at 2 µg/mg of lysate.

  • WB: 1/25 - 1/50.Detects a band of approximately 80 kDa (predicted molecular weight: 80 kDa).(Incubate for 2 hrs at RT for colorimetric detection, can dilute more with ECL+ and with overnight incubation. By Western blot, this antibody detects a band of 80 kDa, which corresponds to the predicted molecular weight of Cdc47 / MCM7.)

  • 1 Image

    Flow Cyt

     Flow Cyt: 1/20

    Flow Cyt: 1/20

  • ShowHide2 Images

    ICC/IF

     ICC/IF: Use a concentrat...Read more →

    ICC/IF: Use a concentration of 1 µg/ml

Target

Function

Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for S-phase checkpoint activation upon UV-induced damage.

Sequence similarities

Belongs to the MCM family.
Contains 1 MCM domain.

Post-translational
modifications

Phosphorylated upon DNA damage, probably by ATM or ATR.

Cellular localization

Nucleus.

Target information above from: UniProt accessionP33993 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • CDABP0042 antibody
  • CDC 47 antibody
  • CDC47 antibody
  • CDC47 homolog antibody
  • DNA replication licensing factor MCM7 antibody
  • Homolog of S. cerevisiae Cdc47 antibody
  • MCM 2 antibody
  • MCM 7 antibody
  • MCM2 antibody
  • Mcm7 antibody
  • MCM7 minichromosome maintenance deficient 7 antibody
  • MCM7_HUMAN antibody
  • Minichromosome Maintainence 7 antibody
  • Minichromosome maintenance complex component 7 antibody
  • Minichromosome maintenance deficient 7 antibody
  • Minichromosome maintenance protein 7 antibody
  • P1.1 MCM3 antibody
  • P1.1-MCM3 antibody
  • P1CDC47 antibody
  • P85MCM antibody
  • PNAS 146 antibody
  • PNAS146 antibody
see all

Anti-MCM7 antibody [47DC141] images:

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - MCM7 antibody [47DC141] (ab2360)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - MCM7 antibody [47DC141] (ab2360)

ab2360 - immunohistochemistry

Formalin fixed paraffin embedded human tonsil stained with MCM7, using ABC and DAB chromagen.

  Immunocytochemistry/ Immunofluorescence - MCM7 antibody [47DC141] (ab2360)

Immunocytochemistry/ Immunofluorescence - MCM7 antibody [47DC141] (ab2360)

This image shows immunostaining of rat brain endothelial cells. Brain endothelial cells were co-cultured with neuronal precursor cells and the nuclear staining represents cells in cell cycle. Primary antibody (ab2360) was used at 1:50 dilution, incubated overnight at 4 oC.  Secondary antibody - Alexafluor (488 nm) at 1:200 dilution, incubated for 2 hours at room temperature.

The picture was kindly supplied by Dr Joseph Corteza Lim and Dr Margery Barrand from University of Cambridge, Department of Pharmacology.

 
 

  Western blot - MCM7 antibody [47DC141] (ab2360)

Western blot - MCM7 antibody [47DC141] (ab2360)

All lanes : Anti-MCM7 antibody [47DC141] (ab2360) at 1/200 dilution

Lane 1 : M phase Xenopus laevis egg extract, whole tissue lysate.
Lane 2 : I phase Xenopus laevis egg extract, whole tissue lysate.

Secondary
HRP conjugated Donkey anti-rabbit IgG
developed using the ECL technique

Predicted band size : 80 kDa
Observed band size : 95 kDa (why is the actual band size different from the predicted?)


Exposure time : 1 minute

This image is courtesy of an anonymous Abreview

See Abreview

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - MCM7 antibody [47DC141] (ab2360)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - MCM7 antibody [47DC141] (ab2360)

ab2360 staining MCM7 in human bladder cancer tissue sections by Immunohistochemistry (formalin fixed sections). Tissue was fixed with formaldehyde and a heat mediated antigen retrieval step was performed using citrate buffer. Tissue was blocked with 5% BSA for 1 hour at room temperature followed by incubation with the primary antibody at a 1/1200 dilution for 1 hour. A HRP-conjugated goat anti-mouse polyclonal was used as secondary antibody un-diluted.

Image kindly supplied by Dr Karin Birkenkamp-Demtroeder through Abreview

See Abreview

  Western blot - MCM7 antibody [47DC141] (ab2360)

Western blot - MCM7 antibody [47DC141] (ab2360)

Lane 1 : Anti-MCM7 antibody [47DC141] (ab2360) at 1/50 dilution
Lane 2 : Anti-MCM7 antibody [47DC141] (ab2360) at 1/200 dilution
Lane 3 : Anti-MCM7 antibody [47DC141] (ab2360) at 1/500 dilution

Lane 1 : Whole cell lysate prepared from SW780 cells
Lane 2 : Whole cell lysate prepared from SW780 cells
Lane 3 : Whole cell lysate prepared from SW780 cells

Lysates/proteins at 25 µg per lane.

Secondary
Goat anti-mouse IgG conjugated to HRP at 1/5000 dilution
developed using the ECL technique

Performed under reducing conditions.

Predicted band size : 80 kDa
Observed band size : 81 kDa (why is the actual band size different from the predicted?)


Exposure time : 10 minutes

Gel run under denaturing conditions 4-12% gradient.

Image kindly supplied by Dr Karin Birkenkamp-Demtroeder through Abreview

See Abreview

  Immunocytochemistry/ Immunofluorescence-MCM7 antibody [47DC141](ab2360)

Immunocytochemistry/ Immunofluorescence-MCM7 antibody [47DC141](ab2360)

ICC/IF image of ab2360 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab2360, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  Flow Cytometry-MCM7 antibody [47DC141](ab2360)

Flow Cytometry-MCM7 antibody [47DC141](ab2360)

Overlay histogram showing HeLA cells stained with ab2360 (red line). The cells were fixed with 100% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab2360, 1/20 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

References for Anti-MCM7 antibody [47DC141] (ab2360)

This product has been referenced in:

  • Nakaoka Het al. Xenopus laevis Ctc1-Stn1-Ten1 (xCST) Protein Complex Is Involved in Priming DNA Synthesis on Single-stranded DNA Template in Xenopus Egg Extract. J Biol Chem 287:619-27 (2012). WB; Xenopus laevis.Read more (PubMed: 22086929) »
  • Nishiyama Aet al. MCM-BP regulates unloading of the MCM2-7 helicase in late S phase. Genes Dev 25:165-75 (2011). WB; Xenopus laevis.Read more (PubMed: 21196493) »

See all 8 publications for this product

Publishing research using ab2360? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"